Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: A comparison with risperidone and exploration of mechanisms involved

Psychopharmacology

Volumn 206, Issue 1, 2009, Pages 39-49

  Mørk, Arne ^a   Witten, Louise M ^a   Arnt, Jørn ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Acetylcholine; Antipsychotic; Dopamine; Glutamate; Haloperidol; Microdialysis; Rat medial prefrontal cortex; Risperidone; Schizophrenia; Sertindole

Indexed keywords

5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ACETYLCHOLINE; DOPAMINE; GLUTAMIC ACID; HALOPERIDOL; RISPERIDONE; SB 742457; SERTINDOLE; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; EXPLORATORY BEHAVIOR; EXTRACELLULAR MATRIX; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; DRUG SYNERGISM; EXTRACELLULAR SPACE; FLUOROBENZENES; GLUTAMIC ACID; HALOPERIDOL; IMIDAZOLES; INDOLES; MALE; MICRODIALYSIS; PIPERIDINES; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, DOPAMINE D2; RISPERIDONE;

EID: 69049088714     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1578-4     Document Type: Article

References (75)

1. Z Abdul-Monim JC Neill GP Reynolds 2007 Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat J Psychopharmacol 21 198 205
2. A Abi-Dargham H Moore 2003 Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia Neuroscientist 9 404 416
3. BW Adams B Moghaddam 2001 Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex Biol Psychiatry 50 750 757
4. Y Ago S Nakamura A Baba T Matsuda 2005 Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex Neuropsychopharmacology 30 43 51
5. AC Arai M Kessler 2007 Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior Curr Drug Targets 8 583 602
6. J Arnt T Skarsfeldt 1998 Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence Neuropsychopharmacology 18 63 101
7. VL Arvanov RY Wang 1999 Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-d-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine J Pharmacol Exp Ther 289 1000 1006
8. MB Assie V Ravailhe V Faucillon A Newman-Tancredi 2005 Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain J Pharmacol Exp Ther 315 265 272
9. JM Azorin N Strub H Loft 2006 A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia Int Clin Psychopharmacol 21 49 56
10. H Benveniste 2009 Glutamate, microdialysis, and cerebral ischemia: lost in translation? Anesthesiology 110 422 425
11. Bogen IL, Risa O, Haug KH, Sonnewald U, Fonnum F, Walaas SI (2008) Distinct changes in neuronal and astrocytic amino acid neurotransmitter metabolism in mice with reduced numbers of synaptic vesicles. J Neurochem (in press)
12. A Bortolozzi L az-Mataix MC Scorza P Celada F Artigas 2005 The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity J Neurochem 95 1597 1607
13. A Bortolozzi L Az-Mataix M Toth P Celada F Artigas 2007 In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain Psychopharmacology (Berl) 191 745 758
14. JM Brooks M Sarter JP Bruno 2007 D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex Neuropharmacology 53 455 463
15. MJ Bubar KA Cunningham 2007 Distribution of serotonin 5-HT2C receptors in the ventral tegmental area Neuroscience 146 286 297
16. SM Cochran M Kennedy CE McKerchar LJ Steward JA Pratt BJ Morris 2003 Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 265 275
17. V Cornea-Hebert M Riad C Wu SK Singh L Descarries 1999 Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat J Comp Neurol 409 187 209
18. LA Dawson HQ Nguyen P Li 2000 In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate Br J Pharmacol 130 23 26
19. LA Dawson HQ Nguyen P Li 2001 The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus Neuropsychopharmacology 25 662 668
20. P Devoto G Flore L Pira G Longu GL Gessa 2004 Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex J Neurochem 88 1003 1009
21. M Didriksen T Skarsfeldt J Arnt 2007 Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics Psychopharmacology (Berl) 193 225 233
22. SN Dijk PT Francis GC Stratmann DM Bowen 1995a NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist Br J Pharmacol 115 1169 1174
23. SN Dijk PT Francis GC Stratmann DM Bowen 1995b Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease J Neurochem 65 2165 2169
24. C Dohmen E Kumura G Rosner WD Heiss R Graf 2005 Extracellular correlates of glutamate toxicity in short-term cerebral ischemia and reperfusion: a direct in vivo comparison between white and gray matter Brain Res 1037 43 51
25. T Enomoto Y Noda T Nabeshima 2007 Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis Methods Find Exp Clin Pharmacol 29 291 301
26. F Fonnum 1984 Glutamate: a neurotransmitter in mammalian brain J Neurochem 42 1 11
27. K Frantz M Harte U Ungerstedt WT O'Connor 2002 A dual probe characterization of dialysate amino acid levels in the medial prefrontal cortex and ventral tegmental area of the awake freely moving rat J Neurosci Methods 119 109 119
28. A Gobert JM Rivet F Lejeune A Newman-Tancredi A dhumeau-Auclair JP Nicolas L Cistarelli C Melon MJ Millan 2000 Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat Synapse 36 205 221
29. P Goetghebeur R Dias 2008 Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat-a back translational study Psychopharmacology (Berl) 202 287 293
30. JA Gray BL Roth 2007 Molecular targets for treating cognitive dysfunction in schizophrenia Schizophr Bull 33 1100 1119
31. B Grayson NF Idris JC Neill 2007 Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat Behav Brain Res 184 31 38
32. T Hajszan C Leranth RH Roth 2006 Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex Biol Psychiatry 60 639 644
33. M Herrera-Marschitz ZB You M Goiny JJ Meana R Silveira OV Godukhin Y Chen S Espinoza E Pettersson CF Loidl G Lubec K Andersson I Nylander L Terenius U Ungerstedt 1996 On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis J Neurochem 66 1726 1735
34. WD Hirst TO Stean DC Rogers D Sunter P Pugh SF Moss SM Bromidge G Riley DR Smith S Bartlett CA Heidbreder AR Atkins LP Lacroix LA Dawson AG Foley CM Regan N Upton 2006 SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models Eur J Pharmacol 553 109 119
35. J Ichikawa H Ishii S Bonaccorso WL Fowler IA O'Laughlin HY Meltzer 2001 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release J Neurochem 76 1521 1531
36. J Ichikawa J Dai HY Meltzer 2002a 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex Brain Res 939 34 42
37. J Ichikawa J Dai IA O'Laughlin WL Fowler HY Meltzer 2002b Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum Neuropsychopharmacology 26 325 339
38. J Ichikawa Z Li J Dai HY Meltzer 2002c Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism Brain Res 956 349 357
39. RL Jakab PS Goldman-Rakic 2000 Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex J Comp Neurol 417 337 348
40. DC Javitt 2007 Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions Int Rev Neurobiol 78 69 108
41. JD Jentsch RH Roth 1999 The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 201 225
42. A Krivoy T Fischel A Weizman 2008 The possible involvement of metabotropic glutamate receptors in schizophrenia Eur Neuropsychopharmacol 18 395 405
43. T Kuroki HY Meltzer J Ichikawa 1999 Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens J Pharmacol Exp Ther 288 774 781
44. LP Lacroix LA Dawson JJ Hagan CA Heidbreder 2004 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex Synapse 51 158 164
45. S Lammel A Hetzel O Hackel I Jones B Liss J Roeper 2008 Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system Neuron 57 760 773
46. J Leysen 2000
47. Z Li J Ichikawa M Huang AJ Prus J Dai HY Meltzer 2005 ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens Psychopharmacology (Berl) 183 144 153
48. Z Li M Huang AJ Prus J Dai HY Meltzer 2007 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus Brain Res 1134 70 78
49. JF Liegeois J Ichikawa HY Meltzer 2002 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner Brain Res 947 157 165
50. X Lopez-Gil Z Babot M Margos-Bosch C Sunol F Artigas A Adell 2007 Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat Neuropsychopharmacology 32 2087 2097
51. KL Marquis AL Sabb SF Logue JA Brennan MJ Piesla TA Comery SM Grauer CR Ashby Jr HQ Nguyen LA Dawson JE Barrett G Stack HY Meltzer BL Harrison S Rosenzweig-Lipson 2007 WAY-163909 [(7bR, 10aR)-1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta-[b][1, 4]diazepino[ 6, 7, 1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity J Pharmacol Exp Ther 320 486 496
52. HY Meltzer SR McGurk 1999 The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizophr Bull 25 233 255
53. E Moor E Schirm J Jacso BH Westerink 1998 Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus Neuroscience 82 819 825
54. Y Noda H Kamei T Mamiya H Furukawa T Nabeshima 2000 Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions Neuropsychopharmacology 23 375 387
55. C O'Grada T Dinan 2007 Executive function in schizophrenia: what impact do antipsychotics have? Hum Psychopharmacol 22 397 406
56. CK Olsen LT Brennum M Kreilgaard 2008 Using pharmacokinetic- pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics Eur J Pharmacol 584 318 327
57. V Parikh K Man MW Decker M Sarter 2008 Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex J Neurosci 28 3769 3780
58. Paxinos G, Watson C (1998) The rat brain in sterotaxic coordinates. Academic, San Diego
59. L Pozzi S Acconcia I Ceglia RW Invernizzi R Samanin 2002 Stimulation of 5-hydroxytryptamine (5-HT(2C)) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex J Neurochem 82 93 100
60. JA Pratt C Winchester A Egerton SM Cochran BJ Morris 2008 Modelling prefrontal cortex deficits in schizophrenia: implications for treatment Br J Pharmacol 153 Suppl 1 S465 S470
61. G Remington S Kapur 2000 Atypical antipsychotics: are some more atypical than others? Psychopharmacology (Berl) 148 3 15
62. C Riemer E Borroni B Levet-Trafit JR Martin S Poli RH Porter M Bos 2003 Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4- sulfonyl) phenylamine, a potent and selective 5-HT6 receptor antagonist J Med Chem 46 1273 1276
63. JS Rodefer TN Nguyen JJ Karlsson J Arnt 2008 Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT(6) receptor antagonist: comparison among antipsychotics Neuropsychopharmacology 33 2657 2666
64. C Routledge SM Bromidge SF Moss GW Price W Hirst H Newman G Riley T Gager T Stean N Upton SE Clarke AM Brown DN Middlemiss 2000 Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist Br J Pharmacol 130 1606 1612
65. CJ Schmidt GM Fadayel 1995 The selective 5-HT2A receptor antagonist, MDL 100, 907, increases dopamine efflux in the prefrontal cortex of the rat Eur J Pharmacol 273 273 279
66. A Schousboe HS Waagepetersen 2006 Glial modulation of GABAergic and glutamatergic neurotransmission Curr Top Med Chem 6 929 934
67. S Shirazi-Southall DE Rodriguez GG Nomikos 2002 Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat Neuropsychopharmacology 26 583 594
68. JM Stone PD Morrison LS Pilowsky 2007 Glutamate and dopamine dysregulation in schizophrenia-a synthesis and selective review J Psychopharmacol 21 440 452
69. PS Talbot M Laruelle 2002 The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development Eur Neuropsychopharmacol 12 503 511
70. HY Tan JH Callicott DR Weinberger 2007 Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia Cereb Cortex 17 Suppl 1 i171 i181
71. N Upton TT Chuang AJ Hunter DJ Virley 2008 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease Neurotherapeutics 5 458 469
72. M van der Zeyden WH Oldenziel K Rea TI Cremers BH Westerink 2008 Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors Pharmacol Biochem Behav 90 135 147
73. BH Westerink JB De Vries 1989 On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals Neurosci Lett 99 197 202
74. MD Wood C Scott K Clarke KJ Cato N Patel J Heath A Worby L Gordon L Campbell G Riley CH Davies A Gribble DN Jones 2006 Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade CNS Neurol Disord Drug Targets 5 445 452
75. DY Zuo YH Zhang Y Cao CF Wu M Tanaka YL Wu 2006 Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior Life Sci 78 2172 2178